About the Zena and Michael A. Wiener Cardiovascular Institute
Our new insights into cardiovascular diseases have dramatically changed our thinking about the fundamental nature of heart disease and our approach to its prevention, diagnosis, and treatment. By integrating three corresponding disciplines — molecular cardiology, regenerative cardiology, and cardiac imaging — Icahn School of Medicine at Mount Sinai's Zena and Michael A. Wiener Cardiovascular Institute has made great headway in advancing research and developing new approaches to enhance patient care.
As cardiovascular diseases have gained a larger foothold globally as the number one killer of people, Mount Sinai has been at the forefront of cardiovascular translational research thanks to the Zena and Michael A. Wiener Cardiovascular Institute. The Institute was created to more closely connect Mount Sinai's research advances with the clinical practice of medicine.
The rapid translation of innovative research concepts into prevention, diagnosis, and therapy means that patients receive multidisciplinary treatment of unprecedented quality. Our programs span patient care from the earliest stages of life — our pediatric cardiologists can detect cardiac disease in the unborn fetus — well into advanced age through specialized geriatric cardiology.
In 2006, the Zena and Michael A. Wiener Cardiovascular Institute dedicated to disease joined forces with the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai dedicated to the promotion of health establishing what is today's Mount Sinai Heart. Today, the Cardiovascular Institute remains the leading translational research hub of Mount Sinai Heart.